BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22342627)

  • 1. Rational design, synthesis and characterization of potent, drug-like monomeric Smac mimetics as pro-apoptotic anticancer agents.
    Bianchi A; Ugazzi M; Ferrante L; Lecis D; Scavullo C; Mastrangelo E; Seneci P
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2204-8. PubMed ID: 22342627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents.
    Peng Y; Sun H; Lu J; Liu L; Cai Q; Shen R; Yang CY; Yi H; Wang S
    J Med Chem; 2012 Jan; 55(1):106-14. PubMed ID: 22148838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of aminopiperidine-based Smac mimetics as IAP antagonists.
    Hennessy EJ; Saeh JC; Sha L; MacIntyre T; Wang H; Larsen NA; Aquila BM; Ferguson AD; Laing NM; Omer CA
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1690-4. PubMed ID: 22264476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
    Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
    ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IAP Proteins Antagonist: An Introduction and Chemistry of Smac Mimetics under Clinical Development.
    Ali R; Singh S; Haq W
    Curr Med Chem; 2018; 25(31):3768-3795. PubMed ID: 29532750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual action Smac mimetics-zinc chelators as pro-apoptotic antitumoral agents.
    Manzoni L; Gornati D; Manzotti M; Cairati S; Bossi A; Arosio D; Lecis D; Seneci P
    Bioorg Med Chem Lett; 2016 Oct; 26(19):4613-4619. PubMed ID: 27578248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design, synthesis and biochemical testing of novel and potent Smac peptido-mimetics.
    Sun H; Nikolovska-Coleska Z; Chen J; Yang CY; Tomita Y; Pan H; Yoshioka Y; Krajewski K; Roller PP; Wang S
    Bioorg Med Chem Lett; 2005 Feb; 15(3):793-7. PubMed ID: 15664859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of small-molecule peptidic and nonpeptidic Smac mimetics.
    Sun H; Nikolovska-Coleska Z; Yang CY; Qian D; Lu J; Qiu S; Bai L; Peng Y; Cai Q; Wang S
    Acc Chem Res; 2008 Oct; 41(10):1264-77. PubMed ID: 18937395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent bivalent Smac mimetics: effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity.
    Sun H; Liu L; Lu J; Bai L; Li X; Nikolovska-Coleska Z; McEachern D; Yang CY; Qiu S; Yi H; Sun D; Wang S
    J Med Chem; 2011 May; 54(9):3306-18. PubMed ID: 21462933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of small-molecule Smac mimetics as IAP antagonists.
    Wang S
    Curr Top Microbiol Immunol; 2011; 348():89-113. PubMed ID: 21072626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.
    Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M
    J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design, synthesis, evaluation, and crystallographic studies of conformationally constrained Smac mimetics as inhibitors of the X-linked inhibitor of apoptosis protein (XIAP).
    Sun H; Stuckey JA; Nikolovska-Coleska Z; Qin D; Meagher JL; Qiu S; Lu J; Yang CY; Saito NG; Wang S
    J Med Chem; 2008 Nov; 51(22):7169-80. PubMed ID: 18954041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening multicomponent reactions for X-linked inhibitor of apoptosis-baculoviral inhibitor of apoptosis protein repeats domain binder.
    Monfardini I; Huang JW; Beck B; Cellitti JF; Pellecchia M; Dömling A
    J Med Chem; 2011 Feb; 54(3):890-900. PubMed ID: 21241056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.
    Li Q; Fang H; Wang X; Hu G; Wang Q; Xu W
    Bioorg Med Chem Lett; 2012 Jan; 22(2):850-3. PubMed ID: 22206607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of smac mimetics; chemotype differentiation based on physical association with caspase regulators and cellular transport.
    Talbott RL; Borzilleri RM; Chaudhry C; Fargnoli J; Shen H; Fairchild C; Barnhart B; Ortega M; McDonagh TE; Vuppugalla R; Vite GD; Hunt JT; Gottardis M; Naglich JG
    Exp Cell Res; 2015 Nov; 338(2):251-60. PubMed ID: 26302264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy.
    Seneci P; Bianchi A; Battaglia C; Belvisi L; Bolognesi M; Caprini A; Cossu F; Franco Ed; Matteo Md; Delia D; Drago C; Khaled A; Lecis D; Manzoni L; Marizzoni M; Mastrangelo E; Milani M; Motto I; Moroni E; Potenza D; Rizzo V; Servida F; Turlizzi E; Varrone M; Vasile F; Scolastico C
    Bioorg Med Chem; 2009 Aug; 17(16):5834-56. PubMed ID: 19620011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPION-Smac mimetic nano-conjugates: putative pro-apoptotic agents in oncology.
    Seneci P; Rizzi M; Ballabio L; Lecis D; Conti A; Carrara C; Licandro E
    Bioorg Med Chem Lett; 2014 May; 24(10):2374-8. PubMed ID: 24736115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smac mimicry and the conformational flexibility of a sweet friend.
    Biopolymers; 2016 May; 106(3):234. PubMed ID: 27163583
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure-based design of potent, conformationally constrained Smac mimetics.
    Sun H; Nikolovska-Coleska Z; Yang CY; Xu L; Liu M; Tomita Y; Pan H; Yoshioka Y; Krajewski K; Roller PP; Wang S
    J Am Chem Soc; 2004 Dec; 126(51):16686-7. PubMed ID: 15612682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological activities of novel hexahydropyrazino[1,2-a]indole derivatives as potent inhibitors of apoptosis (IAP) proteins antagonists with improved membrane permeability across MDR1 expressing cells.
    Shiokawa Z; Hashimoto K; Saito B; Oguro Y; Sumi H; Yabuki M; Yoshimatsu M; Kosugi Y; Debori Y; Morishita N; Dougan DR; Snell GP; Yoshida S; Ishikawa T
    Bioorg Med Chem; 2013 Dec; 21(24):7938-54. PubMed ID: 24169315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.